Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:AFTY BATS:DBJA NASDAQ:EDGE BATS:SPYH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFTYPacer CSOP FTSE China A50 ETF$16.28$16.28$12.54▼$16.77$4.98M0.453,736 shsN/ADBJAInnovator Double Stacker 9 Buffer ETF - January$29.46$29.46$0.00▼$0.00$7.37M0.68N/A13,713 shsEDGEEdge Therapeutics$41.76+1.4%$4.11$0.28▼$17.38$1.32B3.65373,201 shs45 shsSPYHNEOS S&P 500 Hedged Equity Income ETF$53.65+1.1%$52.82$0.00▼$0.00$3.22MN/AN/A8,418 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFTYPacer CSOP FTSE China A50 ETF0.00%0.00%0.00%0.00%+15.15%DBJAInnovator Double Stacker 9 Buffer ETF - January0.00%0.00%0.00%0.00%0.00%EDGEEdge Therapeutics-0.42%-1.23%+1.31%+10.19%+1,091.75%SPYHNEOS S&P 500 Hedged Equity Income ETF-0.34%-1.55%-0.32%+5.43%+5,307,159,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFTYPacer CSOP FTSE China A50 ETFN/AN/AN/AN/AN/AN/AN/AN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AN/AN/AN/AN/AN/AN/AN/AEDGEEdge TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASPYHNEOS S&P 500 Hedged Equity Income ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFTYPacer CSOP FTSE China A50 ETF 0.00N/AN/AN/ADBJAInnovator Double Stacker 9 Buffer ETF - January 0.00N/AN/AN/AEDGEEdge Therapeutics 0.00N/AN/AN/ASPYHNEOS S&P 500 Hedged Equity Income ETF 2.83Moderate Buy$53.65N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFTYPacer CSOP FTSE China A50 ETFN/AN/AN/AN/AN/AN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AN/AN/AN/AN/AN/AEDGEEdge TherapeuticsN/AN/AN/AN/A$0.95 per shareN/ASPYHNEOS S&P 500 Hedged Equity Income ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFTYPacer CSOP FTSE China A50 ETFN/AN/A12.97∞N/AN/AN/AN/AN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AN/A22.55∞N/AN/AN/AN/AN/AEDGEEdge Therapeutics-$40.86MN/A0.00∞N/AN/A-81.29%-56.92%N/ASPYHNEOS S&P 500 Hedged Equity Income ETFN/AN/A25.19∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFTYPacer CSOP FTSE China A50 ETF$0.332.03%N/AN/AN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AN/AN/AN/AN/AEDGEEdge TherapeuticsN/AN/AN/AN/AN/ASPYHNEOS S&P 500 Hedged Equity Income ETF$0.931.73%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFTYPacer CSOP FTSE China A50 ETFN/AN/AN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AN/AN/AEDGEEdge TherapeuticsN/A5.595.59SPYHNEOS S&P 500 Hedged Equity Income ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFTYPacer CSOP FTSE China A50 ETFN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AEDGEEdge Therapeutics28.04%SPYHNEOS S&P 500 Hedged Equity Income ETFN/AInsider OwnershipCompanyInsider OwnershipAFTYPacer CSOP FTSE China A50 ETFN/ADBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/AEDGEEdge Therapeutics37.10%SPYHNEOS S&P 500 Hedged Equity Income ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFTYPacer CSOP FTSE China A50 ETFN/A305,882N/ANot OptionableDBJAInnovator Double Stacker 9 Buffer ETF - JanuaryN/A250,000N/ANot OptionableEDGEEdge TherapeuticsN/A31.51 millionN/ANot OptionableSPYHNEOS S&P 500 Hedged Equity Income ETFN/A60,000N/AN/ASPYH, DBJA, AFTY, and EDGE HeadlinesRecent News About These CompaniesQQQH a Top Performing U.S. Hedged Equity ETFJuly 8, 2025 | etftrends.comE2 ETFs to Hedge Core Equity Portfolios & Earn IncomeJune 3, 2025 | etftrends.comENEOS S&P 500 Hedged Equity Income ETF declares $0.2559 dividendApril 25, 2025 | seekingalpha.comLook to This ETF Income Suite Amid Volatile MarketsApril 11, 2025 | etftrends.comEMedia Sentiment Over TimeSPYH, DBJA, AFTY, and EDGE Company DescriptionsPacer CSOP FTSE China A50 ETF NYSEARCA:AFTY$16.28 0.00 (0.00%) As of 10/15/2024The Pacer CSOP FTSE China A50 ETF (AFTY) is an exchange-traded fund that is based on the FTSE China A 50 index. The fund tracks an index of the 50 largest China A-shares listed on the Shanghai and Shenzhen stock exchanges. AFTY was launched on Mar 12, 2015 and is managed by Pacer.Innovator Double Stacker 9 Buffer ETF - January BATS:DBJA$29.46 0.00 (0.00%) As of 01/2/2024The Innovator Double Stacker 9 Buffer ETF - January (DBJA) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for cumulative capped gains on SPY & QQQ shares while providing a buffer on SPYs loss over a specific holding period. The actively-managed fund holds options and collateral. DBJA was launched on Jan 4, 2021 and is managed by Innovator.Edge Therapeutics NASDAQ:EDGEPDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.NEOS S&P 500 Hedged Equity Income ETF BATS:SPYH$53.65 +0.58 (+1.09%) As of 08/22/2025NEOS ETF Trust - NEOS S&P 500 Hedged Equity Income ETF is an exchange traded fund launched and managed by NEOS Investment Management, LLC. It invests in public equity markets of the United States. The fund invests directly and through derivatives in stocks of companies operating across diversified sectors. It uses derivatives such as options to create its portfolio. The fund invests in growth and value stocks of large-cap companies. The fund employs proprietary research to create its portfolio. NEOS ETF Trust - NEOS S&P 500 Hedged Equity Income ETF is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access